Page last updated: 2024-11-07

1192u90

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1192U90: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127912
CHEMBL ID1188853
SCHEMBL ID9375707
MeSH IDM0259124

Synonyms (16)

Synonym
PDSP1_001055 ,
2-amino-n-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide
1192u90
benzamide, 2-amino-n-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)-
PDSP2_001039
L001475
CHEMBL1188853
glaxo 1192u90
bdbm85048
lle3y7vc87 ,
unii-lle3y7vc87
155289-31-9
SCHEMBL9375707
DTXSID70165872
1192u90 free base
PD067598

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"To assess the potential adverse effects in people of the antipsychotic agent 1192U90, we dosed mice, rats, beagles, and cynomolgus monkeys for up to 3 mo."( The experimental antipsychotic agent 1192U90 targets tapetum lucidum in canine eyes.
Dillberger, JE; Dykstra, MJ; O'Mara, M; Patel, DK; Peiffer, RL,
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]